WO2009090330A3 - Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections - Google Patents

Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections Download PDF

Info

Publication number
WO2009090330A3
WO2009090330A3 PCT/FR2008/001440 FR2008001440W WO2009090330A3 WO 2009090330 A3 WO2009090330 A3 WO 2009090330A3 FR 2008001440 W FR2008001440 W FR 2008001440W WO 2009090330 A3 WO2009090330 A3 WO 2009090330A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
mycoplasma pneumoniae
vitro diagnosis
pneumoniae infections
infections
Prior art date
Application number
PCT/FR2008/001440
Other languages
French (fr)
Other versions
WO2009090330A2 (en
Inventor
Camille Cyncynatus
Hélène NUYTTENS
Original Assignee
Ingen Biosciences
UNIVERSITE VICTOR SEGALEN BORDEAUX 2 Etablissement public à caractère scientifique, culturel et professionnel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingen Biosciences, UNIVERSITE VICTOR SEGALEN BORDEAUX 2 Etablissement public à caractère scientifique, culturel et professionnel filed Critical Ingen Biosciences
Publication of WO2009090330A2 publication Critical patent/WO2009090330A2/en
Publication of WO2009090330A3 publication Critical patent/WO2009090330A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Abstract

The invention relates to the use of the protein 8C2, having the polypeptide sequence ID SEQ N°2, or fragments or variants of said protein, and to the use of sequences coding for said proteins in the field of in vitro diagnosis of a Mycoplasma pneumoniae infection.
PCT/FR2008/001440 2007-10-17 2008-10-14 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections WO2009090330A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0707266 2007-10-17
FR0707266A FR2922648B1 (en) 2007-10-17 2007-10-17 USE OF PROTEIN 8C2 FOR IN VITRO DIAGNOSIS OF MYCOPLASMA PNEUMONIAE INFECTIONS

Publications (2)

Publication Number Publication Date
WO2009090330A2 WO2009090330A2 (en) 2009-07-23
WO2009090330A3 true WO2009090330A3 (en) 2009-10-01

Family

ID=39493621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001440 WO2009090330A2 (en) 2007-10-17 2008-10-14 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections

Country Status (2)

Country Link
FR (1) FR2922648B1 (en)
WO (1) WO2009090330A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2922648B1 (en) * 2007-10-17 2013-01-18 Abag USE OF PROTEIN 8C2 FOR IN VITRO DIAGNOSIS OF MYCOPLASMA PNEUMONIAE INFECTIONS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
WO2006103343A1 (en) * 2005-03-29 2006-10-05 Abag S.A. Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections
FR2922648A1 (en) * 2007-10-17 2009-04-24 Abag Sa Use of mycoplasma protein 8C2 to assay biological samples for antibodies produced as a result of Mycoplasma pneumoniae infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
WO2006103343A1 (en) * 2005-03-29 2006-10-05 Abag S.A. Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections
FR2922648A1 (en) * 2007-10-17 2009-04-24 Abag Sa Use of mycoplasma protein 8C2 to assay biological samples for antibodies produced as a result of Mycoplasma pneumoniae infections

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DANDEKAR D ET AL: "Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 28, no. 17, 1 January 2000 (2000-01-01), pages 3278 - 3288, XP003008959 *
DATABASE EBI 15 June 2007 (2007-06-15), "http://www.ebi.ac.uk/cgi-bin/epo/epofetch?ABU36288", XP002485161 *
DATABASE EBI 19 June 2003 (2003-06-19), "http://www.ebi.ac.uk/cgi-bin/epo/epofetch?ACA40158", XP002485184 *
DATABASE EBI 22 December 2005 (2005-12-22), "http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?-e+([emblidacc-id:U00089]>embl) [embl-acc:U00089]+-vn+2+-noSession", XP002485189 *
DATABASE EBI 23 January 2007 (2007-01-23), "http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?-e+[uniprot-id:FPG_MYCPN] [uniprot-acc:FPG_MYCPN]+-noSession", XP002485190 *
DATABASE Geneseq 22 April 2004 (2004-04-22), XP002537869, Database accession no. GENESEQP:ADH85744 *
HIMMELREICH RALF ET AL: "Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 24, no. 22, 1 January 1996 (1996-01-01), pages 4420 - 4449, XP002172064 *
RÄISÄNEN S ET AL.: "Mycoplasma pneumoniae protein involved in the antibody response in human infection.", JOURNAL OF CLINICAL PATHOLOGY, vol. 37, no. 10, October 1984 (1984-10-01), pages 1129 - 1133, XP009101769, ISSN: 0021-9746 *

Also Published As

Publication number Publication date
FR2922648A1 (en) 2009-04-24
WO2009090330A2 (en) 2009-07-23
FR2922648B1 (en) 2013-01-18

Similar Documents

Publication Publication Date Title
WO2010138263A3 (en) Novel aav 's and uses thereof
WO2005030797A3 (en) Melanocortin receptor agonists
WO2008093058A3 (en) Peptides and their use
WO2009023300A3 (en) Mutants of cholesterol-dependent cytolysins and uses thereof
WO2007053512A3 (en) Novel protein transduction domains and uses therefor
NZ609216A (en) Anticancer fusion protein
NZ599590A (en) Factor involved in latent infection with herpesvirus, and use thereof
EP2135876A3 (en) Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
WO2008127094A3 (en) New virulence factors of streptococcus pnuemoniae
WO2009064366A3 (en) Methods and compositions for protein labeling using lipoic acid ligases
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
WO2010014922A3 (en) Protein purification tags and uses thereof
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
WO2007045019A3 (en) Polyoleosins
WO2008060634A3 (en) Human complement c3 derivatives with cobra venom factor-like function
WO2007093848A3 (en) Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
WO2008113770A3 (en) Anti-androgen peptides and uses thereof in cancer therapy
WO2006097432A3 (en) Keratin-binding desmoplakin polypeptide sequences
MX2010005816A (en) Stat3 epitope peptides.
WO2008015380A8 (en) Integral membrane protein of the pmp-22/emp/mp20/ claudin-like family
WO2009090330A3 (en) Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections
WO2010103515A3 (en) Compositions and methods for prevention and treatment of neurodegenerative diseases
WO2007066018A3 (en) Novel peptides and the biological use thereof
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08870597

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08870597

Country of ref document: EP

Kind code of ref document: A2